Organigram Global Inc. has launched happly — its third U.S. hemp-derived delta-9-THC brand — created for the growing segment of consumers seeking mindful recreation with THC products. 

The launch of happly follows Organigram’s entry into the growing U.S. hemp-derived THC market with its lineup of Collective Project sparkling juices and Fetch sodas earlier this year.

Backed by consumer research, happly is designed for individuals seeking moderation, control and predictability in their cannabis experiences. These consumers prioritize products with lower THC doses formulated to address mood states including sleep, relaxation and socializing. According to Organigram’s U.S. market segmentation study, the mindful recreation segment represents approximately 21% of cannabinoid consumers, highlighting the demand for low-dose, functional products — driven in large part by a younger adult demographic with 63% of this group being under the age of 34.

“happly is more than just a new brand, it is about redefining how hemp-derived THC can be part of everyday life,” said Megan McCrae, SVP, corporate strategy and international growth, Organigram. “It was designed by listening closely to consumers and creating a range of products they’ve been asking for with a focus on moderation, control, predictability and specific benefits. Most importantly, happly reflects a shift toward intentional hemp-derived THC use — designed for everyday moments where consumers are seeking balance and being present rather than excess. Our targeted formulas make that possible, delivering the right effects and a consistent experience.”

At launch, happly will debut with a lineup of three vegan, hemp-derived gummies, each crafted to address a specific consumer mood state: socializing, relaxation or sleep. Each gummy is infused with a blend of cannabinoids and carefully selected functional ingredients. The initial lineup includes:

• socialize: Featuring a Blood Orange Lemonde flavor, each piece has 2.5 mg THC and 25 mg caffeine
• relax: Featuring a Black Cherry Lime flavor, each piece has 2.5 mg THC and 100 mg L-theanine
• sleep: Featuring a Blueberry Lemon flavor, each piece has 2.5 mg THC, 2.5 mg CBN, 10 mg CBD and 100 mg chamomile extract

Each gummy leverages proprietary FAST™nanoemulsion technology. This approach enables a more consistent and predictable onset and offset of effects. Notably, happly is Organigram’s first U.S. brand to incorporate this technology.

“We are incredibly excited to introduce our proprietary FAST nanoemulsion technology to the U.S. market through happly,” said Borna Zlamalik, SVP of innovation and international R&D, Organigram. “This milestone not only marks a significant step in commercializing advanced delivery systems for hemp-derived THC but also showcases the continued success of our product development collaboration with BAT in driving meaningful innovation. At Organigram, we remain steadfast in our commitment to placing innovation and consumer-centric products at the heart of our strategy, ensuring we deliver differentiated experiences and real value for our customers.”

Each slim, reusable tin features 20 gummies. These tins are crafted to offer consumers a discreet, portable and functional option, making them suitable for a variety of occasions throughout the day. 

happly will initially launch via direct-to-consumer online, with shipping available to consumers in 23 states. Expansion into the retail channel is expected later this year.